Trial Profile
Effects of Pioglitazone in Combination With Glimepiride in Comparison to Glimepiride Monotherapy on Metabolic Control in Patients With Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Takeda Pharma
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record, EudraCT2006-002271-41).
- 23 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 23 Jan 2009 Planned patient numbers amended from 100 to 91 as reported by ClinicalTrials.gov.